Four arrested for selling duplicate hand Sanitisers and Masks in Noida

A duplicate company caught for selling hand-sanitisers and masks in Noida on Saturday, a day after the Centre declared the two items as ‘essential commodities’.

“After getting the details from sources, a raid was conducted at around 2.30 PM in commercial hub of Sector 63 where manufacturing of the products were being taken into effect and four people were arrested from the spot. Over 5000 of hand sanitisers and 5000 of face masks have been seized and each item was labelled as ‘SG Group”, according to SDM Rajeev Rai (official who conducted the raid).

On Friday, Centre had declared masks and hand sanitisers under the Essential Commodities Act up to June 30 and offender under the Act may be punished with imprisonment up to seven years or fine or both and can be detained for a maximum of six months.

  • Related Posts

    • Pharma
    • June 4, 2025
    • 65 views
    Delhi Crime branch cracks down on fake cancer drug sellers, arrest six individuals

    New Delhi :  The Crime Branch of Delhi Police has busted a racket selling spurious cancer medicines and injections, arresting six individuals and seizing several high-value spurious cancer drugs on…

    • Pharma
    • June 4, 2025
    • 36 views
    ‘Made in India’ Surgical Robot SSI Mantra’s Hallowed NASDAQ Moment in New York

    New Delhi: It was a hallowed moment of pride for surgical robot SSI Mantra, its architect and robotic surgery wizard Dr Sudheer Srivastava, entire Indian Medtech Industry and ‘Make in…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Delhi Crime branch cracks down on fake cancer drug sellers, arrest six individuals

    Delhi Crime branch cracks down on fake cancer drug sellers, arrest six individuals

    ‘Made in India’ Surgical Robot SSI Mantra’s Hallowed NASDAQ Moment in New York

    ‘Made in India’ Surgical Robot SSI Mantra’s Hallowed NASDAQ Moment in New York

    Zydus to acquire 2 biologics manufacturing units in U.S. from Agenus for $125 million

    Zydus to acquire 2 biologics manufacturing units in U.S. from Agenus for $125 million

    Ananda Pharma advances CBD drug with Phase 1 study listing

    Ananda Pharma advances CBD drug with Phase 1 study listing